KPF
OACCW

K2 Principal Fund’s Oaktree Acquisition Corp III Life Sciences Warrant OACCW Stock Holding History

K2 Principal Fund’s Portfolio OACCW Stock Details OACCW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.7K Hold
39,058
– – ﹤0.01% 445
2025
Q4 		$27.7K Hold
39,058
– – ﹤0.01% 384
2025
Q3 		$29.3K Hold
39,058
– – ﹤0.01% 318
2025
Q2 		$34.4K Hold
39,058
– – ﹤0.01% 264
2025
Q1 		$29.3K Hold
39,058
– – ﹤0.01% 292
2024
Q4 		$34.4K Buy
+39,058
New +$25.5K ﹤0.01% 274

Other funds holding OACCW

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $386M AUM 45.42% 1-Year Est. Return
BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

K2 Principal Fund's OACCW Position: Q1 2026 in Review

K2 Principal Fund held its Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) position steady in Q1 2026 at 39,058 shares worth $20.7K. The position accounts for ﹤0.01% of the portfolio, ranked #445.

K2 Principal Fund first reported a position in OACCW in Q4 2024 and has held it in 6 quarters since. The position peaked at $34.4K in Q2 2025. 26 funds tracked by Wall St. Rank hold OACCW as of Q1 2026.

  • K2 Principal Fund held 39,058 shares of Oaktree Acquisition Corp III Life Sciences Warrant worth $20.7K as of Q1 2026.
  • K2 Principal Fund left its Oaktree Acquisition Corp III Life Sciences Warrant share count unchanged in Q1 2026.
  • Oaktree Acquisition Corp III Life Sciences Warrant made up ﹤0.01% of K2 Principal Fund's portfolio in Q1 2026, its #445 holding.
  • K2 Principal Fund first reported a position in Oaktree Acquisition Corp III Life Sciences Warrant in Q4 2024 and has held it in 6 quarters since.
  • K2 Principal Fund's Oaktree Acquisition Corp III Life Sciences Warrant position peaked at $34.4K in Q2 2025.
  • 26 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Warrant as of Q1 2026.

Based on K2 Principal Fund's 13F filing for Q1 2026, filed 14 May 2026.